ATHM vs IAC

The deterministic scorecard reveals a mixed financial health with a Piotroski F-Score of 6/9 indicating stable but not strong fundamentals, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite attractive valuation metrics such as a low P/E of 13.07 and a Price/Book of 0.79, the company faces significant headwinds including negative earnings momentum, declining revenue growth, and a dangerously high payout ratio exceeding 100%. The stock trades below analyst target of $27.71 yet remains in a prolonged downtrend with a 5Y return of -75.8%, signaling deep market skepticism. Strong gross margins and zero debt are offset by deteriorating profitability trends and weak technical posture.

IAC presents a contradictory profile characterized by a very weak Piotroski F-Score of 2/9, indicating deteriorating operational health, contrasted by a strong liquidity position and deep value valuation. While the company trades at a significant discount to book value (P/B 0.67), it is struggling with negative revenue growth (-10.5% YoY) and highly volatile earnings. The balance sheet remains healthy with low debt/equity (0.34) and a strong current ratio (2.75), providing a safety buffer despite operational headwinds. The overall outlook is neutral as the deep value is offset by shrinking top-line growth and poor fundamental health scores.